SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000318154-23-000061
Filing Date
2023-10-31
Accepted
2023-10-31 07:15:17
Documents
15
Period of Report
2023-10-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMGN-2023.9.30 8-K amgn-20231031.htm   iXBRL 8-K 44862
2 AMGN-2023.9.30 EARNINGS RELEASE amgn-2023930earningsrelease.htm EX-99.1 563676
7 GRAPHIC amgenlogoa.jpg GRAPHIC 13030
  Complete submission text file 0000318154-23-000061.txt   850742

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20231031.xsd EX-101.SCH 3083
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20231031_def.xml EX-101.DEF 17248
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20231031_lab.xml EX-101.LAB 33543
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20231031_pre.xml EX-101.PRE 17599
9 EXTRACTED XBRL INSTANCE DOCUMENT amgn-20231031_htm.xml XML 4509
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 231362271
SIC: 2836 Biological Products, (No Diagnostic Substances)